MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.
Nearly 1 million Windows devices were targeted in recent months by a sophisticated “malvertising” campaign that surreptitiously stole login credentials, cryptocurrency, and other sensitive information ...
Andrea Kasinski, Purdue Institute for Cancer Research (PICR) deputy director and professor of biological sciences in Purdue’s College of Science, has been awarded a competitive translational grant ...
Toripalimab combined with nab-paclitaxel/gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma: Updated results of a phase Ib/II clinical study ...
Carina Biotech Pty Ltd. has submitted an IND application to the FDA to conduct a first-in-human phase I/IIa trial of CNA-3103, its LGR5-targeted chimeric antigen receptor T-cell (CAR-T) therapy ...
CARLSBAD, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for ...
SAN FRANCISCO--(BUSINESS WIRE)--Clarify Health, a leading cloud analytics and value-based payments platform company, announced the launch of Clarify Advance, a new software solution rooted in ...
New Devices Offer Plethora of Communications Options, Capacitive Touch Interface, and Dual-Bank Flash for Software Updates Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback